Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt · Delayed Price · Currency is EGP 586.48
+12.62 (2.20%)
At close: Oct 20, 2026
EGX:CPCI Revenue
Kahira Pharmaceuticals & Chemical Industries Company had revenue of 579.46M EGP in the quarter ending March 31, 2026, with 24.07% growth. This brings the company's total for the last twelve months to 2.39B, up 30.30% year-over-year. In the fiscal year ending June 30, 2025, Kahira Pharmaceuticals & Chemical Industries Company had annual revenue of 2.08B with 52.80% growth. That makes Kahira Pharmaceuticals & Chemical Industries Company the 28,873rd largest company in the world by revenue and 97th in Egypt.
Revenue (ttm)
2.39B
Revenue Growth
+30.30%
P/S Ratio
3.66
Revenue / Employee
1.42M
Employees
1,681
Market Cap
8.76B
Revenue by Geography
- Egypt 1.86B 89.5%
- Iraq 62.93M 3.0%
- Libya 43.31M 2.1%
- Yemen 42.16M 2.0%
- Sudan 33.98M 1.6%
- Jordan 21.06M 1.0%
- Somalia 13.51M 0.7%
- Other 1.68M 0.1%
Fiscal year ended Jun 30, 2025 See the full EGX:CPCI breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.08B | 718.48M | 52.80% |
| Jun 30, 2024 | 1.36B | 355.61M | 35.38% |
| Jun 30, 2023 | 1.01B | -106.87M | -9.61% |
| Jun 30, 2022 | 1.11B | 50.07M | 4.71% |
| Jun 30, 2021 | 1.06B | 51.61M | 5.11% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.